Enzo Biochem, Inc. (ENZ) DCF Valuation

Enzo Biochem, Inc. (Enz) Valoración de DCF

US | Healthcare | Medical - Diagnostics & Research | NYSE
Enzo Biochem, Inc. (ENZ) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Enzo Biochem, Inc. (ENZ) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Descubra el verdadero potencial de Enzo Biochem, Inc. (ENZ) con nuestra calculadora DCF de grado profesional! Ajuste los supuestos clave, explore varios escenarios y examine cómo los cambios afectan la valoración de Enzo Biochem, todo dentro de una sola plantilla de Excel.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 76.0 117.7 107.1 31.1 31.9 30.1 28.4 26.8 25.3 23.9
Revenue Growth, % 0 54.87 -9.05 -70.99 2.72 -5.61 -5.61 -5.61 -5.61 -5.61
EBITDA -27.6 3.3 -15.0 -20.9 -8.3 -8.5 -8.0 -7.6 -7.1 -6.7
EBITDA, % -36.29 2.84 -14.02 -67.42 -26.16 -28.21 -28.21 -28.21 -28.21 -28.21
Depreciation 2.8 2.7 2.8 2.7 1.3 1.3 1.2 1.1 1.1 1.0
Depreciation, % 3.66 2.25 2.64 8.63 3.99 4.23 4.23 4.23 4.23 4.23
EBIT -30.4 .7 -17.8 -23.6 -9.6 -9.8 -9.2 -8.7 -8.2 -7.8
EBIT, % -39.95 0.58778 -16.66 -76.05 -30.15 -32.44 -32.44 -32.44 -32.44 -32.44
Total Cash 47.9 43.5 21.6 82.4 52.4 19.3 18.2 17.2 16.2 15.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 9.1 10.2 4.8 4.8 4.0
Account Receivables, % 12.02 8.66 4.45 15.48 12.5
Inventories 7.8 12.7 15.4 7.9 6.8 5.0 4.7 4.4 4.2 3.9
Inventories, % 10.24 10.75 14.39 25.56 21.41 16.47 16.47 16.47 16.47 16.47
Accounts Payable 8.5 8.1 3.7 3.6 1.4 2.3 2.1 2.0 1.9 1.8
Accounts Payable, % 11.19 6.9 3.47 11.51 4.31 7.48 7.48 7.48 7.48 7.48
Capital Expenditure -2.2 -4.4 -3.5 -2.8 -.5 -1.2 -1.2 -1.1 -1.0 -1.0
Capital Expenditure, % -2.85 -3.77 -3.24 -8.89 -1.71 -4.09 -4.09 -4.09 -4.09 -4.09
Tax Rate, % -165.64 -165.64 -165.64 -165.64 -165.64 -165.64 -165.64 -165.64 -165.64 -165.64
EBITAT -36.1 .3 -22.1 19.2 -25.6 -6.7 -6.3 -6.0 -5.6 -5.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -43.9 -7.8 -24.4 26.4 -25.1 -3.1 -6.0 -5.6 -5.3 -5.0
WACC, % 7.69 7.42 7.69 7.21 7.69 7.54 7.54 7.54 7.54 7.54
PV UFCF
SUM PV UFCF -20.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -5
Terminal Value -92
Present Terminal Value -64
Enterprise Value -84
Net Debt -49
Equity Value -35
Diluted Shares Outstanding, MM 51
Equity Value Per Share -0.69

What You Will Get

  • Real ENZ Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Explore various scenarios to assess Enzo Biochem's future performance.
  • User-Friendly Design: Designed for professionals while remaining easy for newcomers.

Key Features

  • Customizable Research Parameters: Adjust essential inputs such as revenue projections, gross margins, and R&D expenses.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and various financial metrics.
  • High-Precision Accuracy: Incorporates Enzo Biochem’s real-world financial data for credible valuation results.
  • Effortless Scenario Analysis: Evaluate different hypotheses and analyze results with ease.
  • Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.

How It Works

  • Download: Access the ready-to-use Excel file containing Enzo Biochem, Inc.'s (ENZ) financial data.
  • Customize: Modify forecasts, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate multiple projections and compare results instantly.
  • Make Decisions: Utilize the valuation outcomes to inform your investment strategy.

Why Choose This Calculator for Enzo Biochem, Inc. (ENZ)?

  • Accurate Data: Real Enzo Biochem financials provide dependable valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Built-in calculations save you the hassle of starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants focused on biotech.
  • User-Friendly: Easy-to-navigate design and step-by-step guidance cater to users of all experience levels.

Who Should Use This Product?

  • Investors: Evaluate Enzo Biochem's valuation before making stock trades.
  • CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
  • Startup Founders: Understand the valuation strategies of established biotech companies like Enzo Biochem.
  • Consultants: Provide expert valuation assessments for clients in the biotech sector.
  • Students and Educators: Utilize current data to learn and teach valuation practices in biotechnology.

What the Template Contains

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for Enzo Biochem, Inc. (ENZ).
  • Real-World Data: Enzo Biochem’s historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Visualizations such as charts and tables for clear, actionable results.

No products were found matching.